ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,998 | -74.5% | 53,095 | -1.4% | 0.00% | – |
| Q2 2023 | $27,455 | -23.7% | 53,833 | -5.7% | 0.00% | – |
| Q1 2023 | $35,974 | -68.0% | 57,101 | -67.0% | 0.00% | – |
| Q4 2022 | $112,311 | -75.6% | 173,026 | -35.2% | 0.00% | – |
| Q3 2022 | $460,000 | +96.6% | 267,185 | +41.3% | 0.00% | – |
| Q2 2022 | $234,000 | -92.1% | 189,099 | -95.8% | 0.00% | -100.0% |
| Q1 2022 | $2,972,000 | +454.5% | 4,556,509 | +827.2% | 0.00% | – |
| Q4 2021 | $536,000 | -33.3% | 491,420 | +11.2% | 0.00% | – |
| Q3 2021 | $804,000 | -20.0% | 441,895 | +16.1% | 0.00% | – |
| Q2 2021 | $1,005,000 | -20.2% | 380,629 | +8.7% | 0.00% | – |
| Q1 2021 | $1,260,000 | +21.7% | 350,169 | -14.7% | 0.00% | – |
| Q4 2020 | $1,035,000 | -79.3% | 410,652 | -79.3% | 0.00% | -100.0% |
| Q3 2020 | $5,005,000 | -19.4% | 1,986,272 | +5.0% | 0.00% | -50.0% |
| Q2 2020 | $6,206,000 | +713.4% | 1,892,266 | +507.7% | 0.00% | – |
| Q1 2020 | $763,000 | -42.0% | 311,406 | +11.8% | 0.00% | – |
| Q4 2019 | $1,315,000 | -7.5% | 278,507 | -16.1% | 0.00% | – |
| Q3 2019 | $1,421,000 | +49.1% | 331,956 | +103.1% | 0.00% | – |
| Q2 2019 | $953,000 | +62.4% | 163,432 | +7.4% | 0.00% | – |
| Q1 2019 | $587,000 | +178.2% | 152,233 | +35.2% | 0.00% | – |
| Q4 2018 | $211,000 | -47.6% | 112,615 | -10.5% | 0.00% | – |
| Q3 2018 | $403,000 | -12.8% | 125,890 | -17.8% | 0.00% | – |
| Q2 2018 | $462,000 | +80.5% | 153,237 | +134.3% | 0.00% | – |
| Q1 2018 | $256,000 | -57.4% | 65,396 | -55.0% | 0.00% | – |
| Q4 2017 | $601,000 | -38.8% | 145,305 | -9.2% | 0.00% | – |
| Q3 2017 | $982,000 | +506.2% | 159,992 | +515.0% | 0.00% | – |
| Q2 2017 | $162,000 | -77.1% | 26,015 | -76.6% | 0.00% | – |
| Q1 2017 | $706,000 | -40.5% | 111,373 | -49.8% | 0.00% | – |
| Q4 2016 | $1,186,000 | -20.8% | 221,804 | -16.6% | 0.00% | – |
| Q3 2016 | $1,498,000 | +78.1% | 266,058 | +73.6% | 0.00% | – |
| Q2 2016 | $841,000 | -37.7% | 153,275 | -15.8% | 0.00% | – |
| Q1 2016 | $1,351,000 | -64.9% | 182,143 | -60.6% | 0.00% | -100.0% |
| Q4 2015 | $3,844,000 | +26.9% | 462,628 | +37.6% | 0.00% | 0.0% |
| Q3 2015 | $3,029,000 | -75.5% | 336,134 | -67.4% | 0.00% | -66.7% |
| Q2 2015 | $12,384,000 | +16.9% | 1,032,053 | +4.9% | 0.00% | 0.0% |
| Q1 2015 | $10,592,000 | +750.8% | 983,483 | +300.5% | 0.00% | – |
| Q4 2014 | $1,245,000 | +286.6% | 245,591 | +101.2% | 0.00% | – |
| Q3 2014 | $322,000 | +265.9% | 122,049 | +461.8% | 0.00% | – |
| Q2 2014 | $88,000 | -41.3% | 21,725 | -33.7% | 0.00% | – |
| Q1 2014 | $150,000 | -78.7% | 32,788 | -79.8% | 0.00% | – |
| Q4 2013 | $704,000 | -25.3% | 162,220 | -32.3% | 0.00% | – |
| Q3 2013 | $943,000 | +77.9% | 239,444 | -4.7% | 0.00% | – |
| Q2 2013 | $530,000 | +3.9% | 251,261 | +105.2% | 0.00% | – |
| Q4 2012 | $510,000 | -15.4% | 122,475 | +10.6% | 0.00% | – |
| Q3 2012 | $603,000 | +110.8% | 110,714 | +130.7% | 0.00% | – |
| Q2 2012 | $286,000 | +136.4% | 47,999 | +113.5% | 0.00% | – |
| Q1 2012 | $121,000 | – | 22,477 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |